Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FRWW5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,135
Award facts
- Contract value 100% obligated
- $22,134.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,134.80 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on September 27, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's competitive award history and demonstrated capability to fulfill federal medical procurement requirements at varying order values has established it as a key provider through the DLA's pharmaceutical supply chain. This delivery order for Xifaxan, an antibiotic medication used to treat traveler's diarrhea and hepatic encephalopathy, represents a routine procurement supporting the Defense Health Agency and broader military healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FRWW5?
SPE2DB25FRWW5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 27, 2025.
How much is contract SPE2DB25FRWW5 worth?
The government has obligated $22,135 on SPE2DB25FRWW5.
Is contract SPE2DB25FRWW5 an order under another contract?
Yes. SPE2DB25FRWW5 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRWW5 competed?
The extent of competition for SPE2DB25FRWW5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award